PBC News
-
Exact Sciences Launches the Cologuard™ Plus Test, Transforming Colorectal Cancer Screening
The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Madison, Wis., March 31, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of Cologuard Plus™, the…
-
Tyler Gallo, PharmD, Receives ABRC Grant on Heparin-induced Thrombocytopenia
Study seeks to detect people at risk for immune reactions to heparin products Tyler Gallo, PharmD, an assistant research professor at the University of Arizona College of Medicine – Phoenix, received a research grant from the Arizona Biomedical Research Centre (ABRC). The ABRC grant, which is worth $220,000 over the course of three years, will…
-
NAU Confronting substance use disorder in Arizona
Haley Moore thought she knew a lot about substance use disorder. While serving as an emergency medical technician for American Medical Response, she frequently treated patients who were struggling with psychiatric and physical conditions related to alcohol, narcotic and methamphetamine use. But this winter, the NAU master’s student learned even more about how to treat substance…
-
New initiative aims to make nursing degrees more accessible
Danielle Sebbens, associate director of ASU’s Doctor of Nursing Practice program, gives tours of the interior of the mobile simulation unit during the ribbon-cutting event on the ASU West Valley campus on March 26. The unit will allow students on the West Valley and Polytechnic campuses to complete their required simulations without having to drive…
-
New study seeks to combat national kidney shortage, improve availability for organ transplants
Chronic kidney disease affects one in seven adults in the United States. For two in 1,000 Americans, this disease will advance to kidney failure. End-stage renal failure has two primary treatments — dialysis and transplantation. Studies show that, overwhelmingly, kidney transplants offer increased quality of life and lower mortality rates than dialysis. Transplant recipients have a five-year…
-
SEMI, MDM2 to host smart medtech conference in Phoenix from April 22-24
Phoenix will house the three-day 2025 Technology Workshop: Shaping the Future of Advancing Electronics and Medical Technology conference PHOENIX (April 1, 2025) — Greater Phoenix has emerged as a hub of medical device manufacturing driven by its strong healthcare ecosystem and growth in semiconductor capacity. To propel this momentum and accelerate innovation, the region will…
-
Innovative Therapy Shows Promise in Reversing Lung Scarring in Idiopathic Pulmonary Fibrosis
Ken Knox, MD, and Timothy Marlowe, PhD, are innovating therapies to better treat IPF. Researchers develop FN-2012, a novel treatment that could transform the management of IPF and other fibrotic diseases Idiopathic pulmonary fibrosis (IPF) is a lung disease that progressively scars the lungs, making it harder to breathe. According to the Pulmonary Fibrosis Foundation,…
-
Phoenix City Council Expands Enhanced Municipal Services District to Strengthen Innovation and Growth
The expansion integrates the northern portion of the Phoenix Bioscience Core, enhancing support for research, education, and economic development in the heart of Arizona’s innovation hub. PHOENIX (March 28, 2025) – Downtown Phoenix Inc. (DPI) and the City of Phoenix Community and Economic Development Departmentare excited to announce the expansion of the Enhanced Municipal Services District (EMSD), effective January…
-
C-Path’s Predictive Safety Testing Consortium Advances a Transformative Test to Detect Drug Induced Liver Injury
Serum Glutamate Dehydrogenase Activity Enables Sensitive and Specific Diagnosis of Hepatocellular Injury in Humans TUCSON, Ariz., March 27, 2025 – Researchers from Critical Path Institute’s® (C-Path) Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for detecting liver injury, supporting clearer decision-making. Currently, alanine aminotransferase and aspartate aminotransferase (ALT and AST)…
-
Fuel Your Startup’s Growth: Explore Arizona’s Expanded SBIR/STTR Support
The Arizona Commerce Authority (ACA) is dedicated to empowering the state’s startups and small businesses by providing comprehensive resources to navigate and secure funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. These federal initiatives are pivotal in fostering technological innovation and facilitating the commercialization of groundbreaking research. Whether you’re…
Got any book recommendations?